A Multicenter Study to Compare Multiple Doses of Intravitreal Microplasmin Versus Sham Injection for Treatment of Patients With Diabetic Macular Edema (DME)

PHASE2CompletedINTERVENTIONAL
Enrollment

51

Participants

Timeline

Start Date

December 31, 2006

Primary Completion Date

January 31, 2010

Study Completion Date

March 31, 2010

Conditions
Diabetic Macular Edema
Interventions
DRUG

ocriplasmin

Intravitreal injection, single administration

OTHER

Sham injection

Sham intravitreal injection

Trial Locations (15)

2020

ZNA OCMW Antwerpen, Antwerp

21100

Ospedale di Circolo di Varese, Insubria University, Varese

B-9000

University Hospital of Ghent, Ghent

Unknown

University Hospital Leuven, Leuven

Ludwig Maximillian University, Munich

University of Milan, Milan

Azienda Ospedaliero-Universitaria Pisana, Pisa

Instituto Technologico de Oftalmologia SL., Santiago de Compostela

00168

Institute of Ophtalmology, Policlinico A: Gemelli (University Hospital),Catholic University of Sacred Heart, Rome

9700 RB

Academic Hospital Groningen, Groningen

3011 BH

Het Oogziekenhuis Rotterdam, Rotterdam

08022

Institut de Microcirurgia Ocular de Barcelona, Barcelona

08035

Hospital Vall D'Hebron, Barcelona

L7 8XP

Royal Liverpool & Broadgreen Hospital, Liverpool

EC1V 2PD

Moorfields Eye Hospital, London

Sponsors

Lead Sponsor

All Listed Sponsors
lead

ThromboGenics

INDUSTRY